Dysfunction of Nutritive Blood Flow as a Determinant of Anabolic Resistance in Older People
NCT ID: NCT01734616
Last Updated: 2012-11-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2009-09-30
2012-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators will test the hypotheses: (1) muscle nutritive blood flow is a determinant of protein balance, with pharmacologically induced vasodilation acutely stimulating muscle synthesis and reducing breakdown, (2) low nutritive flow in elderly people contributes to anabolic resistance and can be ameliorated by resistance training or nutraceutical flow enhancers.
The investigators wish to study 50 healthy volunteer subjects (not NHS patients) as follows: 18-28 y men (10) and 65-75 y men (40) of comparable body mass index (24-28 kg•m2) all of whom are sedentary and normally undertake no customary resistance training. The investigators have data suggesting sexual dimorphism of anabolic responses to feeding in older subjects so will restrict studies to men only. After obtaining written consent, all subjects will undergo a medical examination, activity questionnaire and DEXA scan. Ten elderly men will undergo a single acute study. In addition the investigators will study 10 young men under the same conditions. Ten more elderly men will undergo an acute study after 20 weeks of supervised whole-body resistance training, as is current practice at a gym site in Derby. Ten more elderly men will undergo a single acute study in which they are given, in addition to the standard acute study protocol 3 drinks of high flavanol cocoa and 3 x 500 mg of vitamin C. If a positive acute effect of the drinks is observed the final ten elderly men will undergo an acute study after a week of ingesting 3 high flavanol cocoa + 1000 mg of vitamin C per day. To optimise details of study conditions the investigators will also study up to 10 normal healthy volunteers 18-75 y simply with the CEUS contrast agent and methacholine infusions, without any blood sampling or biopsies.
Subjects fasted overnight will receive primed constant intravenous (antecubital vein) infusions of stable isotope labelled amino acids for the duration of the study and blood samples will be taken from an arterial cannula and two femoral venous cannulae at regular intervals to quantify tracer enrichment and measure glucose uptake and insulin. In the first phase of the study, subjects' bulk femoral artery blood flow will be measured at 50, 70, 90 and 110 min by Doppler Ultrasound (USS). Nutritive blood flow will be measured in a defined area of the quadriceps in the control leg by Contrast Enhanced Ultrasound (CEUS) using the Phillips iU22 at 110 min. This involves a single intravenous administration of SonoVue® contrast agent. At 120 min the second phase of the study will begin with a dextrose and mixed amino acid intravenous infusion (antecubital vein) for the remainder of the study. Methacholine chloride (Provocholine®; Methapharm Inc.) in NaCl (0.9%, prepared by QMC pharmacy)will be infused (at 2-12 µg/min) into one femoral artery to double femoral artery flow at 150 min. Bulk femoral artery flow will again be measured (Doppler Ultrasound), this time in both legs at 170, 190, 210 and 230 min. Nutritive flow will be measured for a second time, in both legs by CEUS at 230 min. Four muscle biopsies (150-300 mg) of vastus lateralis will be taken according to the protocol and snap-frozen in liquid nitrogen.
The end points will be i. muscle protein synthesis, ii. muscle protein breakdown, iii. bulk femoral blood flow and iv. nutritive femoral blood flow in subjects of different ages or following different exercise or nutraceutical intervention. A power calculation suggests that this study will need 10 subjects per group to detect (with α of 0.05 and β of 0.85) a 25 % difference between groups in biological variables, results the investigators have been able to achieve for similar work in the past.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Young
Young subjects to be controlled to older individuals with interventions
No interventions assigned to this group
Old
Older individuals to compare to young and other older intervention groups
No interventions assigned to this group
Old Exercise
Older individuals studied after an intervention of 20 weeks fully-supervised resistance exercise training
Old Exercise
Old Acute Cocoa
Older individuals studied with the addition of cocoa flavanols during their acute study
Old Acute Cocoa
Old 7 Day Cocoa
Older individuals studied after 7 day supplementation of cocoa flavanols
Old 7 Day Cocoa
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Old Exercise
Old Acute Cocoa
Old 7 Day Cocoa
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* A BMI \< 24 or \> 28 kg•m2.
* Active cardiovascular disease: uncontrolled hypertension (BP \> 160/100), angina, heart failure (class III/IV), arrhythmia, right to left cardiac shunt or recent cardiac event
* Individuals taking beta-adrenergic blocking agents.
* Cerebrovascular disease: previous stroke, aneurysm (large vessel or intracranial).
* Respiratory disease including pulmonary hypertension, COPD, asthma or an FEV1 less than 1.5 l.
* Metabolic disease: hyper and hypo parathyroidism, untreated hyper and hypothyroidism, Cushing's disease, types 1 or 2 diabetes.
* Active inflammatory bowel disease, or renal disease,
* Malignancy
* Recent steroid treatment (within 6 mo), or hormone replacement therapy.
* Clotting dysfunction
* Musculoskeletal or neurological disorders.
* Family history of early (\<55y) death from cardiovascular disease
* Known sensitivity to Definity or methacholine
18 Years
75 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Dunhill Medical Trust
OTHER
University of Nottingham
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John P Williams, PhD, MD
Role: PRINCIPAL_INVESTIGATOR
University of Nottingham
Bethan E Phillips, PhD
Role: STUDY_DIRECTOR
University of Nottingham
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinical Physiology Laboratory, Graduate Entry Medical School, University of Nottingham, Royal Derby Hospital
Derby, Derbyshire, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Phillips B, Williams J, Atherton P, Smith K, Hildebrandt W, Rankin D, Greenhaff P, Macdonald I, Rennie MJ. Resistance exercise training improves age-related declines in leg vascular conductance and rejuvenates acute leg blood flow responses to feeding and exercise. J Appl Physiol (1985). 2012 Feb;112(3):347-53. doi: 10.1152/japplphysiol.01031.2011. Epub 2011 Oct 13.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
F/3/2009
Identifier Type: -
Identifier Source: org_study_id